Depreciation in USD of AXIM BIOTECHNOLOGIES, INC. from 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Axim Biotechnologies, Inc. quarterly/annual Depreciation history and change rate from 2014 to Q2 2024.
  • Axim Biotechnologies, Inc. Depreciation for the quarter ending 30 Jun 2024 was $9.4K, a 17.1% increase year-over-year.
  • Axim Biotechnologies, Inc. Depreciation for the twelve months ending 30 Jun 2024 was $35.2K, a 8.22% increase year-over-year.
  • Axim Biotechnologies, Inc. annual Depreciation for 2023 was $32.6K, a 2.82% increase from 2022.
  • Axim Biotechnologies, Inc. annual Depreciation for 2022 was $31.7K, a 14% increase from 2021.
  • Axim Biotechnologies, Inc. annual Depreciation for 2021 was $27.8K, a 73.6% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $35.2K $9.4K +$1.37K +17.1% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 $33.8K $9.4K +$1.25K +15.4% 01 Jan 2024 31 Mar 2024 10-Q/A 22 May 2024
Q4 2023 $32.6K $8.27K +$46.00 +0.56% 01 Oct 2023 31 Dec 2023 10-K 16 Apr 2024
Q3 2023 $32.5K $8.14K $0 0% 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2023
Q2 2023 $32.5K $8.02K +$620 +8.38% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024
Q1 2023 $31.9K $8.14K +$227 +2.87% 01 Jan 2023 31 Mar 2023 10-Q/A 22 May 2024
Q4 2022 $31.7K $8.22K +$559 +7.3% 01 Oct 2022 31 Dec 2022 10-K 16 Apr 2024
Q3 2022 $31.1K $8.14K +$1.21K +17.4% 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023
Q2 2022 $29.9K $7.4K +$568 +8.31% 01 Apr 2022 30 Jun 2022 10-Q 21 Aug 2023
Q1 2022 $29.3K $7.92K +$1.57K +24.7% 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023
Q4 2021 $27.8K $7.66K 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023
Q3 2021 $6.94K +$1.56K +29.1% 01 Jul 2021 30 Sep 2021 10-Q/A 15 Nov 2022
Q2 2021 $6.83K 01 Apr 2021 30 Jun 2021 10-Q 16 Aug 2022
Q1 2021 $6.35K +$5.51K +657% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022
Q3 2020 $5.37K 01 Jul 2020 30 Sep 2020 10-Q 22 Nov 2021
Q1 2020 $839 $0 0% 01 Jan 2020 31 Mar 2020 10-Q/A 02 Jun 2021
Q1 2019 $839 $0 0% 01 Jan 2019 31 Mar 2019 10-Q/A 02 Jul 2020
Q1 2018 $839 $0 0% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q1 2017 $3.36K $839 $0 0% 01 Jan 2017 31 Mar 2017 10-Q/A 18 May 2018
Q4 2016 $3.36K $839 +$560 +201% 01 Oct 2016 31 Dec 2016 10-K 15 Mar 2018
Q3 2016 $2.8K $839 -$1 -0.12% 01 Jul 2016 30 Sep 2016 10-Q/A 30 Nov 2016
Q2 2016 $2.8K $839 +$839 01 Apr 2016 30 Jun 2016 10-Q/A 25 Aug 2016
Q1 2016 $1.96K $839 +$839 01 Jan 2016 31 Mar 2016 10-Q/A 14 Sep 2017
Q4 2015 $1.12K $279 01 Oct 2015 31 Dec 2015 10-K/A 14 Sep 2017
Q3 2015 $840 01 Jul 2015 30 Sep 2015 10-Q/A 30 Nov 2016
Q2 2015 $0 01 Apr 2015 30 Jun 2015 10-Q/A 25 Aug 2016
Q1 2015 $0 01 Jan 2015 31 Mar 2015 10-Q/A 26 May 2016

AXIM BIOTECHNOLOGIES, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $32.6K +$893 +2.82% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024
2022 $31.7K +$3.9K +14% 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024
2021 $27.8K +$11.8K +73.6% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023
2020 $16K +$12.6K +377% 01 Jan 2020 31 Dec 2020 10-K/A 19 Apr 2022
2019 $3.36K $0 0% 01 Jan 2019 31 Dec 2019 10-K/A 26 Apr 2021
2018 $3.36K $0 0% 01 Jan 2018 31 Dec 2018 10-K/A 20 May 2020
2017 $3.36K $0 0% 01 Jan 2017 31 Dec 2017 10-K 08 Apr 2019
2016 $3.36K +$2.24K +200% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2018
2015 $1.12K +$1.12K 01 Jan 2015 31 Dec 2015 10-K/A 14 Sep 2017
2014 $0 01 Jan 2014 31 Dec 2014 10-K/A 18 Apr 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.